Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Niles › NPI 1578223632
Lab

Hannan Lab INC

Hannan Lab INC was paid $210K by Medicaid between Aug 2022 and Jul 2023, across 12 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 50% of everything it billed.

33Billing provider infoHANNAN LAB INC
NILES, IL 60714
33aNPI1578223632assigned 12/29/2021
28Total paid$210K
24GClaims5,874
24DCodes billed12
24AFirst – last monthAug 2022 – Jul 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#107 of 235
Median peer was paid$123K
This provider vs. median1.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20223,545$136K
20232,329$74K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 50% 1,434 970 $104K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 22% 1,433 1,322 $46K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 16% 1,613 1,093 $34K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 12% 1,174 1,056 $26K
80434 <1% 15 13 $98.26
86905 <1% 14 14 $30.64
87086 Culture, bacterial; quantitative colony count, urine 0% 29 29 $0.00
87088 0% 29 29 $0.00
80155 0% 15 15 $0.00
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 0% 75 75 $0.00
87186 0% 29 29 $0.00
83020 0% 14 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialZAMA KHAN, MOHAMMED HYDER (OWNER)